The current valuation score of Q32 Bio Inc is 8.89, ranking 81 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is 5.45, which is 40.56% below the recent high of 7.67 and 455.36% above the recent low of -19.38.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.